The FDA’s Office of Prescription Drug Promotion issued an Untitled Letter, backdated to September 23, to Tracey M. Henderson, MS, MBA – AstraZeneca’s promotional regulatory affairs review director, ...
Following the FDA’s September announcement of a crackdown on direct-to-consumer drug marketing practices and the subsequent flurry of untitled and warning letters criticizing dozens of Big Pharma ads, ...
Farxiga (dapagliflozin) is a prescription drug that’s used to treat type 2 diabetes. It also helps reduce the risk of complications from certain conditions, including heart failure. Farxiga’s cost may ...
Type 2 diabetes is the most common form of diabetes. It can be diagnosed at any age and increases your risk of several other health problems. Farxiga (far-see-guh) is just one of the many prescription ...
The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback